Personalizing Financial Incentives

Recruiting now · Not applicable

Conditions studied: Obesity & Overweight

In brief

The purpose of this study is to determine the feasibility of providing personalized incentives for dietary self-monitoring and/or interim weight loss to people enrolled in a weight-loss program

Key facts

Study ID

NCT07225426

Run by

University of Utah

People needed

80

Starts

2026-02-04

Expected to finish

2027-02-28

Last updated by the study team

2026-03-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Willing to attend virtual baseline and follow-up data collection visits
• At least 18 years of age
• Verified obesity as defined as a BMI ≥30 kg/m2
• Agree to attend 13 biweekly group classes (virtual) delivered by a registered dietitian
• Agree to review study materials between classes
• Regular access to an unshared smart phone
• Reliable access to internet
• Able to speak and read English
• Desire to lose weight
• Able to connect to a video conference call using a smartphone, tablet or computer with a webcam and microphone
• Ability to download and use Fitbit app daily
• Have or be willing to create a Gmail address
• Physical ability to stand on a scale without support

You may not qualify if…

• Weight loss of at least 10lbs in the month prior to screening
• Weight > 380lbs
• Currently enrolled or enrolled in the previous month in a clinical, research, or community program focusing on lifestyle change that could affect weight
• New user of weight loss medication
• Pregnant, lactating or planning on becoming pregnant during the study
• History of bariatric procedure or planning to have bariatric procedure in the study timeframe
• Residing in a nursing home, skilled nursing facility or assisted living facility
• Impaired hearing
• Significant dementia, drug or alcohol abuse, or unstable psychiatric illness (e.g., schizophrenia, psychosis)
• Current treatment for cancer or being treated for cancer (besides basal cell carcinoma or squamous cell) in the last 6 months
• Use of insulin, sulfonylureas, or meglitinides due to increased risk for hypoglycemia
• Diuretic medication doses higher than hydrochlorothiazide or chlorthalidone 25 mg daily, furosemide 40 mg daily, torsemide 20 mg daily, bumetanide 1 mg daily, or any use of metolazone; use of potassium-sparing diuretics is acceptable
• Unstable heart disease in the 6 months prior to screening
• Chronic kidney disease at stage 4 or higher
• Exertional chest pain
• Pain, fainting, or other conditions that prohibit mild/moderate exercise
• History of ascites requiring paracentesis
• Inducing vomiting to prevent weight gain or counteract the effects of eating an average of 1 time per week or more in the past 3 months*
• Not suitable for study participation due to other reasons at the discretion of the investigators

Where it is running

• University of Utah — Salt Lake City, Utah, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.